CSA: Mental Healthcare in Older Adults With Schizophrenia

• Sponsor: CHU de Reims (Other)
• Overall Status: Unknown status
• CT.gov ID: NCT02884739
• Collaborator: (none)
• Enrollment: 685
• Location: 1
• Duration (Months): 101.9
• Patients Per Site Per Month: 6.7

Study Details

Study Description

Brief Summary

As in the general population, there is a gradual and steady increase in life expectancy of patients with schizophrenia. But this increase is at a smaller scale, with a rate of premature death that is still 2 to 3 times higher than that found in the general population. This excessive early mortality is explained by an overrepresentation of suicide deaths, but also a higher prevalence of somatic diseases, mainly cardiovascular. But today there are only very few epidemiological data on the mortality of patients with schizophrenia, including those aged over 60 years. What are the sociodemographic and clinical characteristics (psychiatric and somatic) of these schizophrenic elderly patients? Do they benefit from a somatic follow-up adequate and systematic? What are their levels of social independence and of quality of life? the answers these questions and the description of the offer of geriatric care and of psychiatric care currently provided by different sectors of psychiatry in France is an indispensable prerequisite for any project to improve the quality of life, state of health and mortality of older patients with schizophrenia.

Condition or Disease	Intervention/Treatment	Phase
Schizophrenia; Chronic Psychiatric Disorder	Other: Data collection

Detailed Description

Evaluate prospectively over 5 years, the rates and causes of mortality in a cohort of schizophrenic patients older than 60 years, followed by adult psychiatry sectors, compared to those patients matched for sex and age and monitored by the same sectors for a chronic psychiatric disorder other than schizophrenia

Study Design

• Study Type: Observational
• Actual Enrollment: 685 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: The Mortality and Its Associated Factors in Schizophrenia Patients Older Than 60 Years
• Study Start Date: Jan 1, 2010
• Anticipated Primary Completion Date: Jul 1, 2018
• Anticipated Study Completion Date: Jul 1, 2018

Arms and Interventions

Arm	Intervention/Treatment
schizophrenia	Other: Data collection
chronic psychiatric disorder other than schizophrenia	Other: Data collection

Outcome Measures

Primary Outcome Measures

1. Death [5 years]

   Death of any causes

Eligibility Criteria

Criteria

• Ages Eligible for Study: 60 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Men or women aged than 60 years with a diagnosis of schizophrenia, according to the DSM-IV criteria

• Men or women aged than 60 years with chronic psychiatric disorder other than schizophrenia

• Patients consenting to participate to the study

• Patients enrolled in the national healthcare insurance program

Exclusion Criteria:

-Disease affecting the central nervous system

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Chu de Reims	Reims		France	51092

Sponsors and Collaborators

• CHU de Reims

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

• Raucher-Chéné D, Hoertel N, Béra-Potelle C, Terrien S, Barrière S, Da Rin D, Tran E, Cuervo-Lombard C, Portefaix C, Limosin F. Mental healthcare in older adults with schizophrenia: results from 118 French public psychiatric departments. Int Psychogeriatr. 2015 Oct;27(10):1749-50. doi: 10.1017/S1041610215001064. Epub 2015 Jul 6.

• Responsible Party: CHU de Reims
• ClinicalTrials.gov Identifier: NCT02884739
• Other Study ID Numbers: PN08001
• First Posted: Aug 31, 2016
• Last Update Posted: Sep 2, 2016
• Last Verified: Sep 1, 2016

• Additional relevant MeSH terms: Schizophrenia; Mental Disorders; Problem Behavior

Study Results

No Results Posted as of Sep 2, 2016